Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Cervical cancer, Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Nasopharyngeal cancer, Skin cancer, Stomach cancer, Vaginal cancer, Vulval cancer
Closed
Phase 1/2
This study is to find what effect nivolumab has on certain cancers that have spread to another part of the body or came back after treatment.
There are 2 groups in this study
people who are having other anti cancer treatment (the Neo adjuvant group)
people whose cancer has spread (the Metastatic group)
This summary is for the Metastatic group. We have information for the Neo adjuvant group.
Recruitment start: 1 October 2015
Recruitment end: 15 January 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jeff Evans
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 12 January 2021
CRUK internal database number: 14152
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
